Work

Phase II trial of capecitabine and rHu-interferon-α-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicity

Year: 2007

Type: article

Study design: Clinical Trial

Source: Urologic Oncology Seminars and Original Investigations

DOI: 10.1016/j.urolonc.2006.02.016

Authors: Ena Segota, Tarek Mekhail, Thomas Olencki, Thomas E. Hutson, Robert Dreicer, Brenda Wacker, Bruno Osterwalder, Paul Elson, Ming Zhou, Ronald M. Bukowski

Institutions: Cleveland Clinic, F. Hoffmann-La Roche AG

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2090859214

FWCI: 0.861

Cites: 34

Cited by: 7

Related to: 10